Clearside Biomedical, Inc. (NASDAQ:CLSD) is a biopharmaceutical company focused on developing therapies to treat eye diseases. The company uses its proprietary SCS Microinjector to deliver drugs to the back of the eye. In the competitive landscape, Clearside competes with other biopharmaceutical companies like Cidara Therapeutics, Selecta Biosciences, vTv Therapeutics, and Corvus Pharmaceuticals.Clearside Biomedical's ROIC is -177.13%, which is significantly lower than its WACC of 17.35%. This negative ROIC ...